Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis
- 25 September 2004
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 75 (24), 2853-2866
- https://doi.org/10.1016/j.lfs.2004.03.040
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cerulein-Induced Acute Pancreatitis in the Rat is Significantly Ameliorated by Treatment With MEK1/2 Inhibitors U0126 and PD98059Pancreas, 2002
- SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinaseProceedings of the National Academy of Sciences, 2001
- Molecular mechanisms of apoptosis in the cardiac myocyteCurrent Opinion in Pharmacology, 2001
- Stress kinase inhibition modulates acute experimental pancreatitisWorld Journal of Gastroenterology, 2001
- Activation of pancreatic acinar cells on isolation from tissue: cytokine upregulation via p38 MAP kinaseAmerican Journal of Physiology-Cell Physiology, 2000
- Inflammatory mediators in acute pancreatitisThe Journal of Pathology, 2000
- The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injuryGastroenterology, 1999
- Stress-Activated Protein Kinase Activation Is the Earliest Direct Correlate to the Induction of Secretagogue-Induced Pancreatitis in RatsBiochemical and Biophysical Research Communications, 1996
- Parallel signal processing among mammalian MAPKsTrends in Biochemical Sciences, 1995
- MAPKs: new JNK expands the groupTrends in Biochemical Sciences, 1994